Cancer therapy targeted at cellular signal transduction mechanisms: Strategies, clinical results, and unresolved issues

This publication has 219 references indexed in Scilit:

• Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
  Cancer Cell, 2009
• Tyrosine phosphorylation: thirty years and counting
  Current Opinion in Cell Biology, 2009
• Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
  Cancer Cell, 2009
• Interaction of antibodies with ErbB receptor extracellular regions
  Experimental Cell Research, 2009
• Targeted therapies in breast cancer: Where are we now?
  European Journal of Cancer, 2008
• Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
  Microvascular Research, 2007
• Ras oncogenes and their downstream targets
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
• Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
  The Lancet, 2005
• Thalidomide
  The Lancet, 2004
• The Hallmarks of Cancer
  Cell, 2000